Xu YF - Search Results

1

Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.

Hu GH, Liu H, Lai P, Guo ZF, Xu L, Yao XD, Zheng JH, Liu M, Xu YF. Hu GH, et al. Among authors: xu yf, xu l. Int J Clin Exp Pathol. 2014 Apr 15;7(5):2143-52. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966922 Free PMC article.

2

Retroperitoneal laparoscopic partial nephrectomy for renal-cell carcinoma in a solitary kidney: report of 56 cases.

Zheng JH, Xu YF, Peng B, Zhang HM, Yan Y, Gao QR, Meng J, Huang JH. Zheng JH, et al. Among authors: xu yf. J Endourol. 2009 Dec;23(12):1971-4. doi: 10.1089/end.2008.0653. J Endourol. 2009. PMID: 19916753 Clinical Trial.

3

Partial cystectomy: Is it a reliable option for the treatment of bladder leiomyosarcoma?

Xu YF, Wang GC, Zheng JH, Peng B. Xu YF, et al. Can Urol Assoc J. 2011 Feb;5(1):E11-3. doi: 10.5489/cuaj.10031. Can Urol Assoc J. 2011. PMID: 21470521 Free PMC article.

4

Protective effects of SP600125 on renal ischemia-reperfusion injury in rats.

Xu YF, Liu M, Peng B, Che JP, Zhang HM, Yan Y, Wang GC, Wu YC, Zheng JH. Xu YF, et al. J Surg Res. 2011 Jul;169(1):e77-84. doi: 10.1016/j.jss.2011.02.021. Epub 2011 Apr 13. J Surg Res. 2011. PMID: 21492872

5

Transcriptome network analysis reveals candidate genes for renal cell carcinoma.

Zhai W, Xu YF, Liu M, Zheng JH. Zhai W, et al. Among authors: xu yf. J Cancer Res Ther. 2012 Jan-Mar;8(1):28-33. doi: 10.4103/0973-1482.95170. J Cancer Res Ther. 2012. PMID: 22531510 Free article.

6

Novel evidence demonstrates that epithelial-mesenchymal transition contributes to nephrolithiasis-induced renal fibrosis.

Liu M, Liu YZ, Feng Y, Xu YF, Che JP, Wang GC, Zheng JH. Liu M, et al. Among authors: xu yf. J Surg Res. 2013 Jun 1;182(1):146-52. doi: 10.1016/j.jss.2012.07.066. Epub 2012 Aug 15. J Surg Res. 2013. PMID: 22920554

7

High level of circulating endothelial progenitor cells positively correlates with serum vascular endothelial growth factor in patients with renal cell carcinoma.

Yang B, Gu W, Peng B, Xu Y, Liu M, Che J, Geng J, Zheng J. Yang B, et al. J Urol. 2012 Dec;188(6):2055-61. doi: 10.1016/j.juro.2012.08.039. Epub 2012 Oct 22. J Urol. 2012. PMID: 23088990

8

A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.

Peng B, Wang GC, Zheng JH, Xia SQ, Geng J, Che JP, Yan Y, Huang JH, Xu YF, Yang B. Peng B, et al. Among authors: xu yf. BJU Int. 2013 Apr;111(4):633-7. doi: 10.1111/j.1464-410X.2012.11610.x. Epub 2012 Oct 29. BJU Int. 2013. PMID: 23107074 Clinical Trial.

9

Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors.

Liu M, Xu YF, Feng Y, Yang FQ, Luo J, Zhai W, Che JP, Wang GC, Zheng JH. Liu M, et al. Among authors: xu yf. J Surg Res. 2013 Jul;183(1):397-404. doi: 10.1016/j.jss.2012.11.041. Epub 2012 Dec 11. J Surg Res. 2013. PMID: 23260235 Clinical Trial.

10

Improvement of erectile function in patients with benign prostatic hyperplasia undergoing transurethral plasmakinetic resection of the prostate.

Zhang HM, Zheng JH, Xu YF, Peng B, Yan Y, Gao QR. Zhang HM, et al. Among authors: xu yf. Int J Urol. 2013 Jul;20(7):724-8. doi: 10.1111/iju.12024. Epub 2013 Jan 10. Int J Urol. 2013. PMID: 23305506 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

652 results

Search Page

Filters